Le Neubourg, France

Elisabeth Thèrése Jeanne Pasquier


Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Elisabeth Thèrése Jeanne Pasquier

Introduction: Elisabeth Thèrése Jeanne Pasquier is a notable inventor from Le Neubourg, France, known for his significant contributions to the field of pharmaceuticals. His pioneering work has led to the development of innovative compounds that hold promise for advancing medical treatments.

Latest Patents: Elisabeth holds a patent for "Quinolinone derivatives as PARP and tank inhibitors." This patent involves compounds represented by a specific formula, which are utilized as PARP inhibitors. These compounds also form the basis of pharmaceutical compositions that have defined characteristics, targeting important mechanisms in cancer therapy.

Career Highlights: Elisabeth has made substantial strides in the pharmaceutical industry, particularly during his tenure at Janssen Pharmaceutica NV. His work is characterized by a commitment to research and development, which has played a critical role in addressing healthcare challenges and enhancing patient outcomes.

Collaborations: Throughout his career, Elisabeth has worked alongside talented individuals such as Jorge Eduardo Vialard and Patrick René Angibaud. These collaborations have fostered a dynamic environment for innovation, allowing for the exploration of new ideas and the advancement of pharmaceutical research.

Conclusion: Elisabeth Thèrése Jeanne Pasquier stands out as an accomplished inventor whose work is shaping the future of medicine. His contributions through patents and collaborations highlight the importance of innovation in the quest for effective therapeutic solutions. As he continues his career, the impact of his inventions is expected to resonate throughout the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…